Product NDC: | 45802-083 |
Proprietary Name: | Erythromycin-Benzoyl Peroxide |
Non Proprietary Name: | erythromycin and benzoyl peroxide |
Active Ingredient(s): | 50; 30 mg/g; mg/g & nbsp; erythromycin and benzoyl peroxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-083 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050557 |
Marketing Category: | NDA |
Start Marketing Date: | 20040329 |
Package NDC: | 45802-083-86 |
Package Description: | 46.6 g in 1 JAR (45802-083-86) |
NDC Code | 45802-083-86 |
Proprietary Name | Erythromycin-Benzoyl Peroxide |
Package Description | 46.6 g in 1 JAR (45802-083-86) |
Product NDC | 45802-083 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | erythromycin and benzoyl peroxide |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20040329 |
Marketing Category Name | NDA |
Labeler Name | Perrigo New York Inc |
Substance Name | BENZOYL PEROXIDE; ERYTHROMYCIN |
Strength Number | 50; 30 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |